FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Eugia US Progesterone Injection Recall

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx O…

Eugia US LLC · East Windsor, NJ

Risk level
Class II
Reported by FDA
Aug 7, 2024
Recall ID
D-0624-2024
Check your lot numberHow we source this data

Summary

Eugia US recalled Progesterone Injection starting Jul 26, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0624-2024 on Aug 7, 2024. Reason: Presence of Particulate Matter: Complaint received of a glass particle in the vial. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

Product description

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

Lot numbers, UPCs & expiration codes

Lot #: CPR230029A

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0624-2024
Classification
Class II
Status
Ongoing
Recall initiated
Jul 26, 2024
FDA report date
Aug 7, 2024
Quantity
17136 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Eugia US LLC

Original FDA data

Every field from FDA enforcement report D-0624-2024, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Ongoing
Country
United States
Event ID
95059
Address
279 Princeton Hightstown Rd
Code information
Lot #: CPR230029A
Postal code
08520-1401
Report date
Aug 7, 2024
Product type
Drugs
Recall number
D-0624-2024
Classification
Class II
Recalling firm
Eugia US LLC
Product quantity
17136 vials
Reason for recall
Presence of Particulate Matter: Complaint received of a glass particle in the vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 26, 2024
Center classification date
Aug 1, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0624-2024, published Aug 7, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls